Comerica Bank Day One Biopharmaceuticals, Inc. Transaction History
Comerica Bank
- $24.4 Billion
- Q4 2024
A detailed history of Comerica Bank transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 345 shares of DAWN stock, worth $2,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345
Previous 345
-0.0%
Holding current value
$2,856
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$53.2 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$48.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$47.7 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$40.4 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$37.5 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $608M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...